TB and HIV in the Central African region: Current knowledge and knowledge gaps

Infection

Volumn 42, Issue 2, 2014, Pages 281-294

  Janssen, S ^a,b,c,d   Huson, M A M ^a,c   Belard S ^a,c,d   Stolp, S ^a,c   Kapata, N ^e,f   Bates, M ^f,g   Van Vugt, M ^a,d   Grobusch, M P ^a,b,c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CERMEL Centre de Recherche Médicale de Lambaréné   (Gabon)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e MINISTRY OF HEALTH   (Zambia)

^f UNIVERSITY TEACHING HOSPITAL   (Zambia)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Central Africa; HIV; Tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ISONIAZID; LAMIVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; STREPTOMYCIN;

AFRICA SOUTH OF THE SAHARA; ANTIVIRAL RESISTANCE; CAMEROON; CAPACITY BUILDING; CASE STUDY; CD4 LYMPHOCYTE COUNT; CENTRAL AFRICA; CHAD; CONGO; DIARRHEA; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; EPIDEMIC; EQUATORIAL GUINEA; EXTRAPULMONARY TUBERCULOSIS; FEVER; GABON; HEALTH CARE SYSTEM; HERPES SIMPLEX KERATITIS; HERPES ZOSTER OPHTHALMICUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KNOWLEDGE; LYMPH NODE BIOPSY; MEDICATION COMPLIANCE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PRURITUS; PUBLIC HEALTH; REVIEW; SEROPREVALENCE; SHORT COURSE THERAPY; SPUTUM SMEAR; SYSTEMATIC REVIEW; THRUSH; TREATMENT RESPONSE; TUBERCULOSIS; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WEIGHT REDUCTION; COINFECTION; COMPLICATION; EPIDEMIOLOGY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; MICROBIOLOGY; MYCOBACTERIUM; PHYSIOLOGY; RESEARCH; STANDARDS; VIROLOGY;

AFRICA, CENTRAL; COINFECTION; HIV; HIV INFECTIONS; HUMANS; KNOWLEDGE; MYCOBACTERIUM; RESEARCH; TUBERCULOSIS;

EID: 84897526937     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0568-y     Document Type: Review

References (147)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/ epidemiology/2013/gr2013/UNAIDS- Global-Report-2013-en.pdf.
2. John MA, Menezes CN, Chita G, Sanne I, Grobusch MP. High tuberculosis and HIV coinfection rate, Johannesburg. Emerg Infect Dis. 2007;13:795-6. (Pubitemid 46698759)
3. World Health Organization (WHO). Global tuberculosis report 2013. 2013. http://www.who.int/tb/publications/global-report/en/.
4. Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page- Shipp L, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet. 2010;375:1798-807.
5. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575-80. (Pubitemid 44780738)
6. Grobusch MP. Drug-resistant and extensively drug-resistant tuberculosis in southern Africa. Curr Opin Pulm Med. 2010;16: 180-5.
7. Fonjungo PN, Mpoudi EN, Torimiro JN, Alemnji GA, Eno LT, Nkengasong JN, et al. Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon. AIDS Res Hum Retroviruses. 2000;16:1319-24.
8. Parris GE. Mechanism and history of evolution of symbiotic HIV strains into lethal pandemic strains: the key event may have been a 1927 trial of pamaquine in Leopoldville (Kinshasa), Congo. Med Hypotheses. 2007;69:838-48. (Pubitemid 47248120)
9. Strickland GT. An epidemic of hepatitis C virus infection while treating endemic infectious diseases in Equatorial Africa more than a half century ago: did it also jump-start the AIDS pandemic? Clin Infect Dis. 2010;51:785-7.
10. Vangroenweghe D. The earliest cases of human immunodeficiency virus type 1 group M in Congo-Kinshasa, Rwanda and Burundi and the origin of acquired immune deficiency syndrome. Philos Trans R Soc Lond B Biol Sci. 2001;356:923-5. (Pubitemid 32614668)
11. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature. 2008;455:661-4.
12. UNAIDS. UNAIDS report on the global AIDS epidemic 2010. 2010. http://www.unaids.org/globalreport/global-report.htm.
13. World Health Organization (WHO). Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. 2010. http://whqlibdoc.who.int/publications/2010/9789241599191-eng.pdf.
14. Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis. 2013;13:529-39.
15. Sibanda EN, Stanczuk G, Kasolo F. HIV/AIDS in Central Africa: pathogenesis, immunological and medical issues. Int Arch Allergy Immunol. 2003;132:183-95. (Pubitemid 37499974)
16. Aghokeng AF, Kouanfack C, Laurent C, Ebong E, Atem-Tambe A, Butel C, et al. Scale-up of antiretroviral treatment in sub- Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. AIDS. 2011;25:2183-8.
17. Mauch V, Weil D, Munim A, Boillot F, Coninx R, Huseynova S, et al. Structure and management of tuberculosis control programs in fragile states-Afghanistan, DR Congo, Haiti, Somalia. Health Policy. 2010;96:118-27.
18. Mbuagbaw J, Eyong I, Alemnji G, Mpoudi N, Same-Ekobo A. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol. 2006;45:280-4. (Pubitemid 43337643)
19. Mbanya DN, Zebaze R, Minkoulou EM, Binam F, Koulla S, Obounou A. Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective. Int J Infect Dis. 2002;6:134-8. (Pubitemid 34793063)
20. Nyambi P, Zekeng L, Kenfack H, Tongo M, Nanfack A, Nkombe I, et al. HIV infection in rural villages of Cameroon. J Acquir Immune Defic Syndr. 2002;31:506-13. (Pubitemid 35448658)
21. Sieleunou I, Souleymanou M, Schönenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health. 2009;14:36-43.
22. Lydié N, Robinson NJ, Ferry B, Akam E, De Loenzien M, Abega S; Study Group on Heterogeneity of HIV Epidemics in African Cities. Mobility, sexual behavior, and HIV infection in an urban population in Cameroon. J Acquir Immune Defic Syndr. 2004;35:67-74. (Pubitemid 38044785)
23. Noeske J, Kuaban C, Cunin P. Are smear-positive pulmonary tuberculosis patients a 'sentinel' population for the HIV epidemic in Cameroon? Int J Tuberc Lung Dis. 2004;8:346-51. (Pubitemid 38624872)
24. Noeske J, Ndi N, Mbondi S. Controlling tuberculosis in prisons against confinement conditions: a lost case? Experience from Cameroon. Int J Tuberc Lung Dis. 2011;15:223-7.
25. Basaras M, Santamaría A, Sarsa M, Gutiérrez E, de Olano Y, Cisterna R. Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea. Trans R Soc Trop Med Hyg. 1999;93:250-2. (Pubitemid 29348813)
26. Tudó G, González-Martín J, Obama R, Rodríguez JM, Franco JR, Espasa M, et al. Molecular epidemiology of tuberculosis in the Bata and Malabo districts of Equatorial Guinea. Int J Tuberc Lung Dis. 2004;8:1458-63. (Pubitemid 40070252)
27. Charpentier C, Koyalta D, Ndinaromtan M, Tchobkréo B, Jenabian MA, Day N, et al. Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of highrisk HIV spread. J Infect Dev Ctries. 2011;5:64-7.
28. Wyss K, Hutton G, N'Diekhor Y. Costs attributable to AIDS at household level in Chad. AIDS Care. 2004;16:808-16. (Pubitemid 39331668)
29. Daugla DM, Daoud S, Tanner M, Zinsstag J, Schelling E. Morbidity patterns in three nomadic communities in Chari-Baguirmi and Kanem, Chad. Med Trop (Mars). 2004;64:469-73.
30. Schelling E, Daoud S, Daugla DM, Diallo P, Tanner M, Zinsstag J. Morbidity and nutrition patterns of three nomadic pastoralist communities of Chad. Acta Trop. 2005;95:16-25. (Pubitemid 40805017)
31. Médecins Sans Frontières. Central African Republic: a state of silent crisis. 2011. http://www.msf.org.uk/sites/uk/files/a-state-of-silent- crisis-en-0.pdf.
32. Nouvel LX, Kassa-Kelembho E, Dos Vultos T, Zandanga G, Rauzier J, Lafoz C, et al. Multidrug-resistant Mycobacterium tuberculosis, Bangui, Central African Republic. Emerg Infect Dis. 2006;12:1454-6. (Pubitemid 44455230)
33. Garin B, Glaziou P, Kassa-Kelembho E, Yassibanda S, Mbelesso P, Morvan J. High mortality rates among patients with tuberculosis in Bangui, Central African Republic. Lancet. 1997;350:1298. (Pubitemid 28036644)
34. Mbendi Nlombi C, Longo-Mbenza B, Mbendi Nsukini S, Muyembe Tamfum JJ, Situakibanza Nanituma H, Vangu Ngoma D. Prevalence of HIV and HBs antigen in blood donors. Residual risk of contamination in blood recipients in East Kinshasa, Democratic Republic of the Congo. Med Trop (Mars). 2001;61:139-42. (Pubitemid 33699830)
35. Kim AA, Malele F, Kaiser R, Mama N, Kinkela T, Mantshumba JC, et al. HIV infection among internally displaced women and women residing in river populations along the Congo River, Democratic Republic of Congo. AIDS Behav. 2009;13:914-20.
36. Bernal MC, Galán MI, Ocete MD, Leyva A, García F, García- Valdecasas J, et al. A seroepidemiological study of human immunodeficiency virus infection in northeast Zaire. Infection. 1994;22:174-7. (Pubitemid 24186373)
37. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7:95-102. (Pubitemid 23069039)
38. Laga M, Alary M, Nzila N, Manoka AT, Tuliza M, Behets F, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet. 1994;344:246-8.
39. Mwandagalirwa K, Jackson EF, McClamroch K, Bollinger R, Ryder RW, Weir SS. Local differences in human immunodeficiency virus prevalence: a comparison of social venue patrons, antenatal patients, and sexually transmitted infection patients in eastern kinshasa. Sex Transm Dis. 2009;36:406-12.
40. Nelson AM, Perriëns JH, Kapita B, Okonda L, Lusamuno N, Kalengayi MR, et al. A clinical and pathological comparison of the WHO and CDC case definitions for AIDS in Kinshasa, Zaïre: is passive surveillance valid? AIDS. 1993;7:1241-5.
41. Tshikuka Mulumba JG, Atua Matindii B, Kilauzi AL, Mengema B, Mafuta J, Eloko Eya Matangelo G, et al. Severity of outcomes associated to types of HIV coinfection with TB and malaria in a setting where the three pandemics overlap. J Community Health. 2012;37:1234-8.
42. Thea DM, St Louis ME, Atido U, Kanjinga K, Kembo B, Matondo M, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med. 1993;329: 1696-702. (Pubitemid 23346920)
43. Van Rie A, Mupuala A, Dow A. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. Pediatrics. 2008;122:e123-8.
44. Ryder RW, Batter V, Kaseka N, Behets F, Sequeira D, M'Boly E, et al. Effect of HIV-1 infection on tuberculosis and fertility in a large workforce in Kinshasa, Democratic Republic of the Congo. AIDS Patient Care STDS. 2000;14:297-304. (Pubitemid 30430035)
45. Henegar C, Behets F, Vanden Driessche K, Tabala M, Bahati E, Bola V, et al. Mortality among tuberculosis patients in the Democratic Republic of Congo. Int J Tuberc Lung Dis. 2012;16: 1199-204.
46. Edmonds A, Lusiama J, Napravnik S, Kitetele F, Van Rie A, Behets F. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol. 2009;38:1612-21.
47. Klausner JD, Ryder RW, Baende E, Lelo U, Williame JC, Ngamboli K, et al. Mycobacterium tuberculosis in household contacts of human immunodeficiency virus type 1-seropositive patients with active pulmonary tuberculosis in Kinshasa, Zaire. J Infect Dis. 1993;168:106-11. (Pubitemid 23178736)
48. Le Coeur S, Halembokaka G, Khlat M, Brouard N, Purhuence F, M'Pelé P, et al. Impact ofAIDS on adult mortality: amorgue-based study in Pointe-Noire, Republic of Congo. AIDS. 2005;19:1683-7. (Pubitemid 41502682)
49. Pictet G, Le Coeur S, M'Pelé P, Brouard N, Lallemant M. Contribution of AIDS to the general mortality in Central Africa: evidence from a morgue-based study in Brazzaville, Congo. AIDS. 1998;12:2217-23. (Pubitemid 28495277)
50. Mabiala-Babela JR, M'Pemba Loufoua AB, Mouko A, Senga P. Pulmonary tuberculosis in infants in Brazzaville, Congo. A review of 117 cases. Med Trop (Mars). 2008;68:167-72. (Pubitemid 351897235)
51. Mabiala-Babela JR, Makosso E, Senga P. Retrospective study of 61 cases of multifocal tuberculosis in children in Brazzaville, Congo. Med Trop (Mars). 2008;68:41-4. (Pubitemid 351482256)
52. Mpemba Loufoua-Lemay AB, Nzingoula S. Peritoneal tuberculosis in children at the University Hospital Center of Brazzaville: 35 cases. Arch Pediatr. 2003;10:356-7.
53. M'Pemba Loufoua-Lemay AB, Youndouka JM, Pambou B, Nzingoula S. Child tuberculosis at the teaching hospital of Brazzaville from 1995 to 2003. Bull Soc Pathol Exot. 2008;101:303-7.
54. M'Boussa J, Yokolo D, Pereira B, Ebata-Mongo S. A flare-up of tuberculosis due to war in Congo Brazzaville. Int J Tuberc Lung Dis. 2002;6:475-8. (Pubitemid 34601862)
55. M'Pemba Loufoua Lemay AB, Mabiala Babela JR, Bantsimba T, Nzingoula S. Tuberculosis and HIV/AIDS co-infection in children: experience carried out in paediatric service of the teaching Hospital of Brazzaville, Republic of Congo (1995-2004). Bull Soc Pathol Exot. 2007;100:51-2.
56. Tevi-Benissan C, Okome M, Makuwa M, Nkoume MN, Lan-soud- Soukate J, Georges A, et al. HIV-2 infection and HIV-1/ HIV-2 dual reactivity in patients with and without AIDS-related symptoms in Gabon. Emerg Infect Dis. 1998;4:130-1. (Pubitemid 28347431)
57. Mounanga M, Revangue BS. HIV-1 seroprevalence in pregnant women in Libreville (Gabon). J Gynecol Obstet Biol Reprod (Paris). 1993;22:509-12. (Pubitemid 23299154)
58. Caron M, Lekana-Douki SE, Makuwa M, Obiang-Ndong GP, Biba O, Nkoghé D, et al. Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, Central Africa. BMC Infect Dis. 2012;12:64.
59. Bertherat E, Georges-Courbot MC, Nabias R, Georges AJ, Renaut A. Seroprevalence of four sexually transmitted diseases in a semi-urban population of Gabon. Int J STD AIDS. 1998;9:31-6. (Pubitemid 28108834)
60. Schrijvers D, Delaporte E, Peeters M, Dupont A, Meheus A. Seroprevalence of retroviral infection in women with different fertility statuses in Gabon, western equatorial Africa. J Acquir Immune Defic Syndr. 1991;4:468-70.
61. Mvé MT, Bisvigou U, Barry NC, Ondo CE, Nkoghe D. Reasons for stopping and restarting tuberculosis treatment in Libreville (Gabon). Sante. 2010;20:31-4.
62. Nkoghe D, Toung Mve M, Nnegue S, Okome Nkoume M, Iba BJ, Hypolite J, et al. HIV seroprevalence among tuberculosis patients in Nkembo Hospital, Libreville, Gabon. Short note. Bull Soc Pathol Exot. 2005;98:121-2. (Pubitemid 41019827)
63. Mouba JF, Miloundja J, Mimbila-Mayi M, Ndjenkam FT, N'zouba L. Cervical lymph node tuberculosis in Libreville: epidemiology, diagnosis, and therapy. Sante. 2011;21:165-8.
64. Kombila DU, Moussavou-Kombila JB, Grobusch MP, Lell B. Clinical and laboratory features of tuberculosis within a hospital population in Libreville, Gabon. Infection. 2013;41:737-9.
65. Mbopi-Kéou FX, Dempouo Djomassi L, Monebenimp F. Study of factors related to adherence to antiretroviral therapy among patients followed at HIV/AIDS Unit in the District Hospital of Dschang, Cameroon. Pan Afr Med J. 2012;12:55.
66. Ebana Mvogo C, Ellong A, Bella AL, Luma H, Achu Joko H. Ocular complications of HIV/AIDS in Cameroon: is there is any correlation with the level of CD4 lymphocytes count? Bull Soc Belge Ophtalmol. 2007;305:7-12.
67. Ibara JR, Itoua C, Gathse A, Obengui, Gassaye D, Nkoua JL, et al. Acquired immunodeficiency syndrome in elderly persons in a tropical zone. Apropos of 175 cases in the Congo. Bull Soc Pathol Exot. 2002;95:100-2.
68. Okome Nkoumou MM, Okome Essima R, Obiang Ndong GP, Okome Miame F. Clinical and laboratory findings in HIVinfected patients at the Jeanne Ebori Foundation in Libreville, Gabon (2002-2005). Med Trop (Mars). 2007;67:357-62. (Pubitemid 350146350)
69. Kuaban C, Fotsin JG, Koulla-Shiro S, Ekono MR, Hagbe P. Lower lung field tuberculosis in Yaounde, Cameroon. Cent Afr J Med. 1996;42:62-5. (Pubitemid 126481360)
70. Kuaban C, Koulla-Shiro S, Lekama Assiene T, Hagbe P. Tuberculosis screening of patient contacts in 1993 and 1994 in Yaounde, Cameroon. Med Trop (Mars). 1996;56:156-8. (Pubitemid 26264214)
71. Pefura Yone EW, Kuaban C, Simo L. Tuberculous pleural effusion in Yaounde, Cameroon: The influence of HIV infection. Rev Mal Respir. 2011;28:1138-45.
72. Sume GE, Hoshen M, Bita G, Kabore S, Nzima VN. Treatment outcome of TB/HIV positive and negative smear positive pulmonary tuberculosis patients treated using daily self-administered therapy in a Cameroonian district hospital. East Afr Med J. 2009;86:469-75.
73. Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaounde, Cameroon. East Afr Med J. 2009;86:219-25.
74. Breton G, Service YB, Kassa-Kelembho E, Mbolidi CD, Minssart P. Tuberculosis and HIV in Bangui, Central African Republic: strong prevalence and management difficulties. Med Trop (Mars). 2002;62:623-6. (Pubitemid 46417030)
75. Chartier L, Leng C, Sire JM, Le Minor O, Saman M, Bercion R, et al. Factors associated with negative direct sputum examination in Asian and African HIV-infected patients with tuberculosis (ANRS 1260). PLoS One. 2011;6:e21212.
76. Ondounda M, Ilozue C, Mounguengui D, Magne C, Nzenze JR. Clinical and radiological features of tuberculosis during HIV infection in Libreville, Gabon. Med Trop (Mars). 2011;71: 253-6.
77. Engohan Alloghe E, Toung Mve M, Ramarojoana S, Iba J, Nkoghe D. Epidemiology of childhood tuberculosis in Libreville, Gabon from 1997 to 2001. Med Trop (Mars). 2006;66: 469-71. (Pubitemid 350203886)
78. Cuadros DF, Branscum AJ, García-Ramos G. No evidence of association between HIV-1 and malaria in populations with low HIV-1 prevalence. PLoS One. 2011;6:23458.
79. Roka M, Goñi P, Rubio E, Clavel A. Prevalence of intestinal parasites in HIV-positive patients on the island of Bioko, Equatorial Guinea: its relation to sanitary conditions and socioeconomic factors. Sci Total Environ. 2012;432:404-11.
80. Mbopi-Kéou FX, Grésenguet G, Mayaud P, Weiss HA, Gopal R, Matta M, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis. 2000;182: 1090-6.
81. Mbopi-Kéou FX, Legoff J, Grésenguet G, Si-Mohamed A, Matta M, Mayaud P, et al. Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women. J Acquir Immune Defic Syndr. 2003;33:121-4. (Pubitemid 36793143)
82. Békondi C, Bernede C, Passone N, Minssart P, Kamalo C, Mbolidi D, et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis. 2006;10:387-95. (Pubitemid 44209231)
83. Modia O'Yandjo A, Foidart JM, Rigo J. Influence of HIV-1 and placental malaria co-infection on newborn biometry and Apgar scores in Kinshasa, Democratic Republic of Congo. J Gynecol Obstet Biol Reprod (Paris). 2011;40:460-4.
84. Perret JL, Moussavou-Kombila JB, Delaporte E, Minko-Mi- Etoua D, Pemba LF, Boguikouma JB, et al. Prevalence of hepatitis B and C virus, HTLV-1 and HIV in type B lymphoproliferative syndromes in Gabon. Bull Soc Pathol Exot. 2003;96:275-8. (Pubitemid 38011312)
85. World Health Organization (WHO). Progress report 2011: Global HIV/AIDS response. 2011. http://www.who.int/hiv/pub/progress-report2011/en/.
86. Jao J, Palmer D, Leus I, Tih P, Baweja M, Klotman M, et al. Prevalence and predictors of proteinuria in HIV-infected and uninfected pregnant women in Cameroon. Nephrol Dial Transplant. 2011;26:3051-3.
87. Nkenfou CN, Lobé EE, Ouwe-Missi-Oukem-Boyer O, Sosso MS, Dambaya B, Gwom LC, et al. Implementation of HIV early infant diagnosis and HIV type 1 RNA viral load determination on dried blood spots in Cameroon: challenges and propositions. AIDS Res Hum Retroviruses. 2012;28:176-81.
88. Torpey K, Kasonde P, Kabaso M, Weaver MA, Bryan G, Mukonka V, et al. Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr. 2010;54:415-22.
89. Kouanda S, Tougri H, Cisse M, Simpore J, Pietra V, Doulougou B, et al. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso. AIDS Care. 2010;22:843-50.
90. Namukwaya Z, Mudiope P, Kekitiinwa A, Musoke P, Matovu J, Kayma S, et al. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009. J Acquir Immune Defic Syndr. 2011;56:69-75.
91. Azcoaga-Lorenzo A, Ferreyra C, Alvarez A, Palma PP, Velilla E, del Amo J. Effectiveness of a PMTCT programme in rural Western Kenya. AIDS Care. 2011;23:274-80.
92. Fitzgerald FC, Bekker LG, Kaplan R, Myer L, Lawn SD, Wood R. Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. S Afr Med J. 2010;100: 827-31.
93. Mirkuzie AH, Hinderaker SG, Sisay MM, Moland KM, Mørkve O. Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study. J Int AIDS Soc. 2011; 14:50.
94. Ikechebelu JI, Ugboaja JO, Kalu SO, Ugochukwu EF. The outcome of prevention of mother to child transmission (PMTCT) of HIV infection programme in Nnewi, southeast Nigeria. Niger J Med. 2011;20:421-5.
95. Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngolé E, et al. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon. Antivir Ther. 2012;17:321-6.
96. Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised noninferiority trial. Lancet Infect Dis. 2011;11:825-33.
97. Van Rompaey S, Kimfuta J, Kimbondo P, Monn C, Buvé A. Operational assessment of access to ART in rural Africa: the example of Kisantu in Democratic Republic of the Congo. AIDS Care. 2011;23:686-93.
98. Ryder RW, Kamenga C, Jingu M, Mbuyi N, Mbu L, Behets F. Pregnancy and HIV-1 incidence in 178 married couples with discordant HIV-1 serostatus: additional experience at an HIV-1 counselling centre in the Democratic Republic of the Congo. Trop Med Int Health. 2000;5:482-7. (Pubitemid 30622526)
99. Laurent C, Meilo H, Guiard-Schmid JB, Mapouré Y, Noël JM, M'Bangué M, et al. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. Clin Infect Dis. 2005;41: 108-11. (Pubitemid 40863752)
100. Marcellin F, Boyer S, Protopopescu C, Dia A, Ongolo-Zogo P, Koulla-Shiro S, et al. Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116). Trop Med Int Health. 2008;13:1470-8.
101. Billong SC, Fokam J, Nkwescheu AS, Kembou E, Milenge P, Tsomo Z, et al. Early warning indicators for HIV drug resistance in Cameroon during the year 2010. PLoS One. 2012;7:e36777.
102. Ndziessi G, Boyer S, Kouanfack C, Cohen J, Marcellin F, Moatti JP, et al. Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trial. PLoS One. 2012;7:e36118.
103. Muko KN, Ngwa VC, Chigang LC, Ngwa IG, Meiburg A, Shu EN. Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: a rural case study in Cameroon. SAHAR J. 2004;1:107-13.
104. Yumo HA, Mbanya D, Kuaban C, Neuhann F. Outcome assessment of a global fund grant for tuberculosis control at the district level in rural Cameroon. Int J Tuberc Lung Dis. 2011;15:352-7.
105. Njozing BN, Edin KE, San Sebastián M, Hurtig AK. Voices from the frontline: counsellors' perspectives on TB/HIV collaborative activities in the Northwest Region, Cameroon. BMC Health Serv Res. 2011;11:328.
106. Kuaban C, Bercion R, Jifon G, Cunin P, Blackett KN. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon. Int J Tuberc Lung Dis. 2000;4:427-32. (Pubitemid 30256845)
107. Mauclère P, Loussert-Ajaka I, Damond F, Fagot P, Souquières S, Monny Lobe M, et al. Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS. 1997;11:445-53. (Pubitemid 27113005)
108. Yamaguchi J, McArthur CP, Vallari A, Coffey R, Bodelle P, Beyeme M, et al. HIV-1 Group N: evidence of ongoing transmission in Cameroon. AIDS Res Hum Retroviruses. 2006;22: 453-7. (Pubitemid 43787771)
109. Brennan CA, Bodelle P, Coffey R, Devare SG, Golden A, Hackett J Jr, et al. The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr. 2008;49:432-9.
110. Burda ST, Konings FA, Williams CA, Anyangwe C, Nyambi PN. HIV-1 CRF09-cpx circulates in the North West Province of Cameroon where CRF02-AG infections predominate and recombinant strains are common. AIDS Res Hum Retroviruses. 2004;20:1358-63. (Pubitemid 40065932)
111. Carr JK, Wolfe ND, Torimiro JN, Tamoufe U, Mpoudi-Ngole E, Eyzaguirre L, et al. HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics? Retrovirology. 2010;7:39.
112. Konings FA, Haman GR, Xue Y, Urbanski MM, Hertzmark K, Nanfack A, et al. Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms. J Acquir Immune Defic Syndr. 2006;42:331-41. (Pubitemid 44050012)
113. Mboudjeka I, Bikandou B, Zekeng L, Takehisa J, Harada Y, Yamaguchi-Kabata Y, et al. Genetic diversity of HIV-1 group M from Cameroon and Republic of Congo. Arch Virol. 1999;144:2291-311. (Pubitemid 30057170)
114. Ndembi N, Takehisa J, Zekeng L, Kobayashi E, Ngansop C, Songok EM, et al. Genetic diversity of HIV type 1 in rural eastern Cameroon. J Acquir Immune Defic Syndr. 2004;37:1641-50. (Pubitemid 39658207)
115. Ndembi N, Iwamoto S, Ngansop C, Lemey P, Abimiku A, Mbanya D, et al. High frequency of HIV-1 dual infections in Cameroon, West Central Africa. J Acquir Immune Defic Syndr. 2011;57:e25-7.
116. Soares EA, Makamche MF, Siqueira JD, Lumngwena E, Mbuagbaw J, Kaptue L, et al. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease. J Clin Virol. 2010;48:173-9.
117. Yamaguchi J, Bodelle P, Vallari AS, Coffey R, McArthur CP, Schochetman G, et al. HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. AIDS Res Hum Retroviruses. 2004;20:944-57. (Pubitemid 39369701)
118. Vèras NM, Santoro MM, Gray RR, Tatem AJ, Lo Presti A, Olearo F, et al. Molecular epidemiology of HIV type 1 CRF02-AG in Cameroon and African patients living in Italy. AIDS Res Hum Retroviruses. 2011;27:1173-82.
119. Faria NR, Suchard MA, Abecasis A, Sousa JD, Ndembi N, Bonfim I, et al. Phylodynamics of the HIV-1 CRF02-AG clade in Cameroon. Infect Genet Evol. 2012;12:453-60.
120. Ortiz M, Sanchez I, Gonzalez MP, León MI, Abeso N, Asumu E, et al. Molecular epidemiology of HIV type 1 subtypes in equatorial guinea. AIDS Res Hum Retroviruses. 2001;17:851-5. (Pubitemid 32692400)
121. Koyalta D, Charpentier C, Beassamda J, Rey E, Si-Mohamed A, Djemadji-Oudjeil N, et al. High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad. Clin Infect Dis. 2009;49:155-9.
122. Vidal N, Koyalta D, Richard V, Lechiche C, Ndinaromtan T, Djimasngar A, et al. High genetic diversity of HIV-1 strains in Chad, West Central Africa. J Acquir Immune Defic Syndr. 2003;33:239-46. (Pubitemid 36793161)
123. Djoko CF, Rimoin AW, Vidal N, Tamoufe U, Wolfe ND, Butel C, et al. High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo. AIDS Res Hum Retroviruses. 2011;27:323-9.
124. Mokili JL, Wade CM, Burns SM, Cutting WA, Bopopi JM, Green SD, et al. Genetic heterogeneity of HIV type 1 subtypes in Kimpese, rural Democratic Republic of Congo. AIDS Res Hum Retroviruses. 1999;15:655-64. (Pubitemid 29205669)
125. Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, et al. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol. 2000;74:10498-507.
126. Bikandou B, Takehisa J, Mboudjeka I, Ido E, Kuwata T, Miyazaki Y, et al. Genetic subtypes of HIV type 1 in Republic of Congo. AIDS Res Hum Retroviruses. 2000;16:613-9. (Pubitemid 30235986)
127. Candotti D, Tareau C, Barin F, Joberty C, Rosenheim M, M'Pele P, et al. Genetic subtyping and V3 serotyping of HIV type 1 isolates in Congo. AIDS Res Hum Retroviruses. 1999;15:309-14. (Pubitemid 29101934)
128. Niama FR, Toure-Kane C, Vidal N, Obengui P, Bikandou B, Ndoundou Nkodia MY, et al. HIV-1 subtypes and recombinants in the Republic of Congo. Infect Genet Evol. 2006;6:337-43. (Pubitemid 43964477)
129. Caron M, Makuwa M, Souquière S, Descamps D, Brun-Vézinet F, Kazanji M. Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa. AIDS Res Hum Retroviruses. 2008;24:1225-8.
130. Mintsa-Ndong A, Caron M, Plantier JC, Makuwa M, Le Hello S, Courgnaud V, et al. High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa. AIDS Res Hum Retroviruses. 2009;25:411-8.
131. Burda ST, Viswanath R, Zhao J, Kinge T, Anyangwe C, Tinyami ET, et al. HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon. J Med Virol. 2010;82:187-96.
132. Charpentier C, Gody JC, Tisserand P, Matta M, Fournier J, Mbitikon O, et al. Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria. Arch Virol. 2011;156:1603-6.
133. Ragupathy V, Zhao J, Wood O, Tang S, Lee S, Nyambi P, et al. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon. Virol J. 2011;8:185.
134. Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, et al. Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. J Med Virol. 2012;84:721-7.
135. Fokam J, Salpini R, Santoro MM, Cento V, Perno CF, Colizzi V, et al. Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon. Pediatr Infect Dis J. 2011;30:1062-8.
136. Péré H, Charpentier C, Mbelesso P, Dandy M, Matta M, Moussa S, et al. Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic. AIDS Res Hum Retroviruses. 2012;28:315-23.
137. Charpentier C, Gody JC, Tisserand P, Matta M, Péré H, Fournier J, et al. Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic. Antivir Ther. 2011;16:1347-50.
138. Charpentier C, Gody JC, Mbitikon O, Moussa S, Matta M, Péré H, et al. Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. AIDS Res Hum Retroviruses. 2012;28:87-94.
139. Vergne L, Malonga-Mouellet G, Mistoul I, Mavoungou R, Mansaray H, PeetersM, et al. Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries. J Acquir Immune Defic Syndr. 2002;1:165-8. (Pubitemid 34164888)
140. Assam-Assam JP, Penlap VB, Cho-Ngwa F, Tedom JC, Ane- Anyangwe I, Titanji VP. Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infect Dis. 2011;11:94.
141. Bercion R, Kuaban C. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995. Int J TubercLungDis. 1997;1:110-4. (Pubitemid 127509665)
142. Kassa-Kelembho E, Bobossi-Serengbe G, Takeng EC, Nambea- Koisse TB, Yapou F, Talarmin A. Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int J Tuberc Lung Dis. 2004;8:574-8. (Pubitemid 38625062)
143. Diguimbaye C, Hilty M, Ngandolo R, Mahamat HH, Pfyffer GE, Baggi F, et al. Molecular characterization and drug resistance testing of Mycobacterium tuberculosis isolates from Chad. J Clin Microbiol. 2006;44:1575-7.
144. Abdelhadi O, Ndokaïn J, Ali MM, Friocourt V, Mortier E, HeymB. Drug resistance testing of Mycobacterium tuberculosis isolates from sputum in Chad. Bull Soc Pathol Exot. 2012;105:16-22.
145. Minime-Lingoupou F, Pierre-Audigier C, Kassa-Kélémbho E, Barilone N, Zandanga G, Rauzier J, et al. Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int J Tuberc Lung Dis. 2010;14:782-5.
146. Kabedi MJ, Kashongwe M, Kayembe JM, Mumba Ngoyi D, Mampasi P, Mbaya P, et al. Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC). Bull Soc Pathol Exot. 2007;100:275-6.
147. Mounguengui D, Ondounda M, Mandji Lawson JM, Fabre M, Gaudong L, Mangouka L, et al. Multi-resistant tuberculosis at the hôpital d'instruction des armées de Libreville (Gabon) about 16 cases. Bull Soc Pathol Exot. 2012;105:1-4.